captvivekjain
Long

Aurobindo Pharma will catalize your investment surely

NSE:AUROPHARMA   AUROBINDO PHARMA
71 3 7
Scrip is at Rs             691 having risen handsomely with good volumes after a full fledged correction and hibernating for quite some time.
With USFDA behind it and a good number of ANDAs in the offing and due for sanction from USFDA in the coming year, it is sure to catapult to much newer heights.
Resistance being at Rs             725 ~ 750, a breather and then a sustained rise to Rs             1050+ cannot be ruled out.
Buy and hold with a stoploss of Rs             . 665 or so.
I believe in this company fundamentals and although technically the chart structure isn't too strong, the company is doing good and I'm sure this should reflect in it's price movement very soon as well.

For now, it's a good opportunity to buy Aurobindo Pharma.
Reply
i am having doubt, wait for confirmation sell on rise is applicable on this scrip as monthly chart patterns are still negative
Reply
captvivekjain avirrathi
@avirrathi,
I hope your doubts will be cleared in the coming few weeks.
This scrip is completely bottomed out and selling it will be foolish !!!
Reply
EN English (IN)
EN English
EN English (UK)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out